✦ LIBER ✦

Outcome differences in patients with advanced epithelial ovarian, primary peritoneal and fallopian tube cancers treated with and without bevacizumab

✍ Scribed by Randall, L.; Burger, R.; Nguyen, H.; Kong, G.; Bookman, M.; Fleming, G.; Monk, B.; Mannel, R.; Birrer, M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Patterns of recurrence in advanced epith

✍ Katharine M. Esselen; Noah Rodriguez; Whitfield Growdon; Carolyn Krasner; Neil S 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 263 KB

Recurrence patterns after extended treat

✍ Dao, Minh D.; Alwan, Laura M.; Gray, Heidi J.; Tamimi, Hisham K.; Goff, Barbara 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 178 KB

Bevacizumab Combination Therapy: A Revie

✍ Dhillon, Sohita 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 503 KB

Beyond tertiary cytoreduction in patient

✍ K.K. Shih; D.S. Chi; R.R. Barakat; M.M. Leitao Jr. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 238 KB

Time from completion of chemotherapy to

✍ Randall, L.; Burger, R.; Nguyen, H.; Kong, G.; Bookman, M.; Fleming, G.; Monk, B 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 181 KB

Altered recurrence patterns after extend

✍ Dao, M.; Alwan, L.; Goff, B.; Liao, J. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 227 KB